Anesthetic drugs & techniques

Systematic review with meta-analysis of relative risk of prolonged times to tracheal extubation with desflurane versus sevoflurane or isoflurane

J Clin AnesthPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

In conclusion, when emergence from general anesthesia with different drugs are compared with sevoflurane or isoflurane, suitable benchmarks quantifying rapidity of emergence are reductions in the incidence of prolonged extubation achieved by desflurane, approximately 65% and 78%, respectively.

Study context

Population
Patients in published randomized clinical trials of humans comparing desflurane with sevoflurane or isoflurane67 papers · 78 comparisons
Participants
5,167 patients
Comparison
Desflurane vs sevoflurane or isoflurane
Outcome
Prolonged time to tracheal extubation (≥15 min from end of surgery or anesthetic discontinuation to extubation in the OR)
Methodological detailsDerSimonian-Laird random effects, Knapp-Hartung adjustment, generalized pivotal methods, Studies of high quality (23/78) or moderate quality (55/78)
  • DerSimonian-Laird random effects
  • Knapp-Hartung adjustment
  • Generalized pivotal methods
  • Studies of high quality (23/78) or moderate quality (55/78)

Pooled result

As reported in the abstract

Incidence of prolonged extubation

Relative reduction

65%

95% CI 49%–76%P < 0.0001

Desflurane vs Sevoflurane

Relative reduction

78%

95% CI 58%–89%P = 0.0001

Desflurane vs Isoflurane

Further pooled results

Meta-regression of studies' RR on quality, industry funding, year of publication

No significant associations (all six meta-regressions)
P ≥ 0.35

Original publication

Systematic review with meta-analysis of relative risk of prolonged times to tracheal extubation with desflurane versus sevoflurane or isoflurane. J Clin Anesth. Published 21 July 2023. doi:10.1016/j.jclinane.2023.111210

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.